Biofrontera AG

 

May 27, 2012

 

OVERVIEW  | NEWS  | MULTIMEDIA  | RESEARCH

News Reader RSS  Biofrontera AG
 
 Biofrontera AG; Patient Treatment In Phase III Study With BF-200 ALA For Actinic Keratosis Completed
OCT 7, 2008 18:59 - Article Views: 209
Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
 

Site Search
 
    All Languages
Team Trev Zero Race 2010

Companies in the News

ABN Newswire on iPhone/iPad

Download from Apple

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile
 
City Index - A Better Way To Trade

209 Article Views In All Supported Languages
 

RESEARCH